A new research report by Transparency Market Research predicts that the global pulmonary edema market will grow significantly in the years to come owing to the rising occurrence of cardiovascular diseases, especially cardiac attacks. Pulmonary edema is one of the primary reasons for deaths amongst cardiovascular diseases. The rising number of people diagnosed with cardiac attacks is likely to boost the global pulmonary edema market.
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2250
The report, titled “Pulmonary edema Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” states that the market will be benefited by the changing lifestyles and the rising investment in research and development activities. The awareness about various preventive therapies is also growing across the globe, which is another factor expected to propel the global market. Considering the rising occurrence of cardiovascular diseases, the market for therapeutic medicines and methodologies is expected to be promising.
The report briefs readers about the current trends and changing trends in the global pulmonary edema market. As per WHO, in 2012, around 82% of 38 mn deaths across the globe were due to non-communicable diseases. The majority of deaths were due to one of the non-communicable diseases such as chronic respiratory diseases, cancer, cardiovascular diseases, and diabetes. Of all these, most of the deaths were caused due to cardiovascular diseases, accounting for 17.5 million deaths, i.e., 46.2% of the total deaths caused by non-communicable diseases. The majority of these deaths happened due to pulmonary edema.
The report on the global pulmonary edema market highlights key diagnostic technologies, key geographical markets, and therapeutic methods. Diagnostic technologies comprise liver and renal function tests, x-ray, ECG, and blood tests done for electrolyte concentration. Mechanical or natural ventilation, antibiotics, and respiratory distress agents such as loop diuretics, antipyretics, and morphine are some of the therapeutic techniques for pulmonary edema. Key players operating in the global market are concentrating on improving various therapeutic methods for pulmonary edema. By introducing new therapeutic methods, key players aim to maintain their dominance in the global market. Advancements in the technology, rising medical infrastructure, and rising investment in research and development activities for discovering new therapeutic methods are expected to benefit the global market.
Some of the prominent players operating in the global pulmonary edema market are MayoClinic, University of Heidelberg, University of Oxford, Synvista Therapeutics includes, Inc., and Hopitaux Universitaires de Gene ve. Leading companies are aiming to target many nations across Asia Pacific, North America, Europe, and Rest of the World. With the entry of new companies, the market for pulmonary edema will be highly competitive and promising, predict the report’s authors. Governments of many nations are increasing their funding for the development of new therapeutic methods, thus is predicted to propel the global market for pulmonary edema.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453